Table 2.
Patients who suffered from complications versus those who did not.
| Complications | p Value | ||||
|---|---|---|---|---|---|
| No (n = 124) | Yes (n = 22) | ||||
| Nonagenarians | 28 | (22.58%) | 7 | (31.82%) | 0.506 |
| Age | 80 | (72–87) | 85 | (79–91) | 0.023 * |
| Male | 87 | (70.16%) | 15 | (68.18%) | 1.000 |
| Total bilirubin > 2 mg/dl | 50 | (40.32%) | 8 | (36.36%) | 0.910 |
| INR > 1.15 f | 14 | (11.29%) | 4 | (18.18%) | 0.478 |
| Platelet < 150(109/L) | 37 | (29.84%) | 6 | (27.27%) | 1.000 |
| ASA class 3–4 | 44 | (35.48%) | 13 | (59.09%) | 0.036 * |
| ESRD f | 6 | (4.84%) | 5 | (22.73%) | 0.012 * |
| Pancreatitis f | 19 | (15.32%) | 1 | (4.55%) | 0.311 |
| CBD stone | 83 | (66.94%) | 15 | (68.18%) | 1.000 |
| Benign stricture f | 15 | (12.10%) | 1 | (4.55%) | 0.467 |
| Perihilar cancer f | 10 | (8.06%) | 1 | (4.55%) | 1.000 |
| Periampulla vater cancer | 18 | (14.52%) | 3 | (13.64%) | 1.000 |
| Cancer | 25 | (20.16%) | 5 | (22.73%) | 0.778 |
| EST | 103 | (83.06%) | 17 | (77.27%) | 0.547 |
| Precut | 24 | (19.35%) | 3 | (13.64%) | 0.766 |
| ERBD | 41 | (33.06%) | 7 | (31.82%) | 1.000 |
| Lithotripsy f | 8 | (6.45%) | 1 | (4.55%) | 1.000 |
Chi-Sqaure test. f Fisher’s Exact test. * p < 0.05. ASA: American Society of Anesthesiologists; INR: international normalized ratio; ESRD: end stage renal disease; CBD: common bile duct; EST: endoscopic sphincterotomy; ERBD: endoscopic retrograde biliary drainage.